IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
Dimethyl fumarate (DMF) is a therapy for multiple sclerosis (MS) with undetermined mechanism of action. Here the authors find that clinical response to DMF associates with decrease in IL-17-producing CD8+ T cells (Tc17), delineate molecular pathways involved, and show that DMF suppresses Tc17 pathog...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e2f0c2356834c5db881aabfe09b997c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2e2f0c2356834c5db881aabfe09b997c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2e2f0c2356834c5db881aabfe09b997c2021-12-02T15:36:02ZIL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis10.1038/s41467-019-13731-z2041-1723https://doaj.org/article/2e2f0c2356834c5db881aabfe09b997c2019-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-13731-zhttps://doaj.org/toc/2041-1723Dimethyl fumarate (DMF) is a therapy for multiple sclerosis (MS) with undetermined mechanism of action. Here the authors find that clinical response to DMF associates with decrease in IL-17-producing CD8+ T cells (Tc17), delineate molecular pathways involved, and show that DMF suppresses Tc17 pathogenicity in a mouse model of MS.Christina LückelFelix PicardHartmann RaiferLucia Campos CarrascosaAnna GuralnikYajuan ZhangMatthias KleinStefan BittnerFalk SteffenSonja MoosFederico MariniRenee GlouryFlorian C. KurschusYing-Yin ChaoWilhelm BertramsVeronika SexlBernd SchmeckLynn BonettiMelanie GrusdatMichael LohoffChristina E. ZielinskiFrauke ZippAxel KalliesDirk BrennerMichael BergerTobias BoppBjörn TackenbergMagdalena HuberNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-15 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Christina Lückel Felix Picard Hartmann Raifer Lucia Campos Carrascosa Anna Guralnik Yajuan Zhang Matthias Klein Stefan Bittner Falk Steffen Sonja Moos Federico Marini Renee Gloury Florian C. Kurschus Ying-Yin Chao Wilhelm Bertrams Veronika Sexl Bernd Schmeck Lynn Bonetti Melanie Grusdat Michael Lohoff Christina E. Zielinski Frauke Zipp Axel Kallies Dirk Brenner Michael Berger Tobias Bopp Björn Tackenberg Magdalena Huber IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
description |
Dimethyl fumarate (DMF) is a therapy for multiple sclerosis (MS) with undetermined mechanism of action. Here the authors find that clinical response to DMF associates with decrease in IL-17-producing CD8+ T cells (Tc17), delineate molecular pathways involved, and show that DMF suppresses Tc17 pathogenicity in a mouse model of MS. |
format |
article |
author |
Christina Lückel Felix Picard Hartmann Raifer Lucia Campos Carrascosa Anna Guralnik Yajuan Zhang Matthias Klein Stefan Bittner Falk Steffen Sonja Moos Federico Marini Renee Gloury Florian C. Kurschus Ying-Yin Chao Wilhelm Bertrams Veronika Sexl Bernd Schmeck Lynn Bonetti Melanie Grusdat Michael Lohoff Christina E. Zielinski Frauke Zipp Axel Kallies Dirk Brenner Michael Berger Tobias Bopp Björn Tackenberg Magdalena Huber |
author_facet |
Christina Lückel Felix Picard Hartmann Raifer Lucia Campos Carrascosa Anna Guralnik Yajuan Zhang Matthias Klein Stefan Bittner Falk Steffen Sonja Moos Federico Marini Renee Gloury Florian C. Kurschus Ying-Yin Chao Wilhelm Bertrams Veronika Sexl Bernd Schmeck Lynn Bonetti Melanie Grusdat Michael Lohoff Christina E. Zielinski Frauke Zipp Axel Kallies Dirk Brenner Michael Berger Tobias Bopp Björn Tackenberg Magdalena Huber |
author_sort |
Christina Lückel |
title |
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_short |
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_full |
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_fullStr |
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_full_unstemmed |
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_sort |
il-17+ cd8+ t cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/2e2f0c2356834c5db881aabfe09b997c |
work_keys_str_mv |
AT christinaluckel il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT felixpicard il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT hartmannraifer il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT luciacamposcarrascosa il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT annaguralnik il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT yajuanzhang il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT matthiasklein il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT stefanbittner il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT falksteffen il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT sonjamoos il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT federicomarini il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT reneegloury il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT florianckurschus il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT yingyinchao il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT wilhelmbertrams il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT veronikasexl il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT berndschmeck il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT lynnbonetti il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT melaniegrusdat il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT michaellohoff il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT christinaezielinski il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT fraukezipp il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT axelkallies il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT dirkbrenner il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT michaelberger il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT tobiasbopp il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT bjorntackenberg il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT magdalenahuber il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis |
_version_ |
1718386344422539264 |